High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.7M
$2,689,086
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-09 | $111,045 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -10.6%
|
2026-03-04 | $175,933 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-04 | $110,540 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -10.8%
|
2026-03-04 | $199,897 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-02 | $22,248 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-01-29 | $184 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-01-29 | $29,610 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $48,187 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $84,016 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $102,703 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $49,170 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $14,472 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $3,920 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $17,837 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $30,556 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $134,286 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $51,270 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $18,200 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -19.0%
|
2025-12-09 | $201,648 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-01 | $61,276 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-10-29 | $52,978 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $7,958 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 SellΔOwn -29.3%
|
2025-09-30 | $292,361 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 SellΔOwn -32.8%
|
2025-09-30 | $233,851 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $36,203 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Other
|
2025-09-30 | $40,707 | M | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $41,354 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $46,330 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 SellΔOwn -13.1%
|
2025-09-30 | $58,204 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -29.9%
|
2025-09-16 | $452,850 | S | Form 4 |